A new perspective in cancer immunotherapy: PD-1 on myeloid cells takes center stage in orchestrating immune checkpoint blockade

See allHide authors and affiliations

Science Immunology  03 Jan 2020:
Vol. 5, Issue 43, eaaz8128
DOI: 10.1126/sciimmunol.aaz8128

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Immunology

Navigate This Article